ReviewKidney international supplements2020
Considerations on equity in management of end-stage kidney disease in low- and middle-income countries.
Review in Kidney international supplements, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- A case study integrating scenario thinking with dialysis policymaking in Thailand.Communications medicine · 2025Article
- Balancing patient choice and health system capacity: a system dynamics model of dialysis in Thailand.BMC medicine · 2025Article
- Quality of Life in Patients with CKD With Catastrophic Health Care Expenditures: A National Study From Thailand.Kidney medicine · 2025Article
- Addressing social responsibility of kidney healthcare facilities in Africa.Frontiers in health services · 2025Article
- Dynamic measurements of geographical accessibility considering traffic congestion using open data: a cross-sectional assessment for haemodialysis services in Cali, Colombia.Lancet regional health. Americas · 2024Article
- Chronic Kidney Disease in Brazil: Current Status and Recommended Improvements.Kidney diseases (Basel, Switzerland) · 2024Review
- A qualitative study on the lived experiences of individuals with end-stage kidney disease (ESKD) accessing haemodialysis in Northern Ghana.BMC nephrology · 2024Article
- Landscape of kidney replacement therapy provision in low- and lower-middle income countries: A multinational study from the ISN-GKHA.PLOS global public health · 2024Article
- Causal effects of systemic inflammatory regulators on chronic kidney diseases and renal function: a bidirectional Mendelian randomization study.Frontiers in immunology · 2023Article
- Dialysis Decision Making and the Patient Experience: Lessons From Pakistan.Kidney medicine · 2022Article
- Review
- NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.Lancet (London, England) · 2022Review
- The hidden financial catastrophe of chronic kidney disease under universal coverage and Thai "Peritoneal Dialysis First Policy".Frontiers in public health · 2022Article
- Addressing the Ethical Challenges of Providing Kidney Failure Care for Children: A Global Stance.Frontiers in pediatrics · 2022Review
- Diagnostic Yield of Population-Based Screening for Chronic Kidney Disease in Low-Income, Middle-Income, and High-Income Countries.JAMA network open · 2021Article
- Choice of dialysis modality among patients initiating dialysis: results of the Peridialysis study.Clinical kidney journal · 2021Article
- Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.American journal of nephrology · 2021Review
- Sustainable Development Goals relevant to kidney health: an update on progress.Nature reviews. Nephrology · 2021Review
- Dispelling the myths of providing dialysis in low- and middle-income countries.Nature reviews. Nephrology · 2021Article
- Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries.Journal of the American Society of Nephrology : JASN · 2020Review
Corrections and comments
- Commented on by
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care). Implementation of KRT programs has the potential to exacerbate inequity unless equity is deliberately addressed. In this review, we summarize discussions on equitable provision of KRT in low- and middle-income countries and suggest areas for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.